Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition

@article{Simmons2004CyclooxygenaseIT,
  title={Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition},
  author={Daniel L. Simmons and Regina M. Botting and Timothy Hla},
  journal={Pharmacological Reviews},
  year={2004},
  volume={56},
  pages={387 - 437}
}
Nonsteroidal anti-inflammatory drugs (NSAIDs) represent one of the most highly utilized classes of pharmaceutical agents in medicine. All NSAIDs act through inhibiting prostaglandin synthesis, a catalytic activity possessed by two distinct cyclooxygenase (COX) isozymes encoded by separate genes. The discovery of COX-2 launched a new era in NSAID pharmacology, resulting in the synthesis, marketing, and widespread use of COX-2 selective drugs. These pharmaceutical agents have quickly become… 
View on ASPET
pharmrev.aspetjournals.org
1,616 Citations
Highly Influential Citations
119
Background Citations
679
Methods Citations
17
Results Citations
7

1,616 Citations

Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.

  • B. Rm
  • Medicine, Biology
  • 2006
The discovery of cyclooxygenase-2 and the establishment of its structure led to the development of selective inhibitors of this enzyme, such as celecoxib and rofecoxib, with potent anti-inflammatory actions but with reduced gastrotoxic effects.

Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.

  • R. Botting
  • Medicine, Biology
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • 2006
The discovery of cyclooxygenase-2 and the establishment of its structure led to the development of selective inhibitors of this enzyme, such as celecoxib and rofecoxib, with potent anti-inflammatory actions but with reduced gastrotoxic effects.

Selective COX-1 inhibition: A therapeutic target to be reconsidered.

This review would elucidate the most recent findings on selective COX-1 inhibition and their relevance to human pathology such as cancer, neuro-inflammation, cardioprotection, fever and pain, and focus on the design and development of new highly selective COx-1 inhibitors, useful tools in pharmacological studies.

Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.

Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs

This review identifies key structural features of the cyclooxygenases, breaks down their active site into regional binding pockets to facilitate comparisons between structures, and explores similarities and differences in the binding modes of the wide variety of ligands that have been characterized in complex with the enzymes.

Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases.

The most recent findings on selective COX-2 inhibition and their relevance to human pathology are elucidate in inflammatory pathologies characterized by a prolonged pro-inflammatory status, including autoimmune diseases, metabolic syndrome, obesity, atherosclerosis, neurodegenerative diseases, chronic obstructive pulmonary disease, arthritis, chronic inflammatory bowel disease and cardiovascular pathologies.

Cyclooxygenase-2: Biology of Prostanoid Biosynthesis and Metabolism

COX-2 is the target of NSAIDs, traditional and coxibs, thus leading to therapeutic effects and cardiovascular hazard, in some individuals, and the discovery of these novel effects of (R) enantiomers ofNSAIDs opens the way to develop novel analgesic drugs based on this mechanism of action.

Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs

Both pathways and their cross talk and pharmaceutical potentials for future therapeutic de- velopment based on these signaling transduction pathways are discussed.

Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.

Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold

E-DMSS analogues may be useful probes of COx-1 biology in vivo and promising leads for COX-1-targeted therapeutic agents.
...

593 References

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

The structures of unliganded murine COX-2 and complexes with flurbiprofen, indomethacin and SC-558, a selective COx-2 inhibitor, determined are explained and some of the conformational changes associated with time-dependent inhibition are demonstrated.

Cyclooxygenase-2 inhibitors in tumorigenesis (part I).

  • M. Taketo
  • Biology
    Journal of the National Cancer Institute
  • 1998
Accumulating evidence indicates that nonsteroidal anti-inflammatory drugs can reduce the incidence of colorectal cancers in human and experimental animals and can reduced the polyp number and size in patients with familial adenomatous polyposis.

Variants of cyclooxygenase-1 and their roles in medicine.

  • D. Simmons
  • Biology, Medicine
    Thrombosis research
  • 2003

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

  • M. Taketo
  • Medicine, Biology
    Journal of the National Cancer Institute
  • 1998
Accumulating evidence indicates that NSAIDs can reduce the incidence of colorectal cancers in human and experimental animals and can reduced the number and size of polyps in patients with familial adenomatous polyposis.

Cyclooxygenase inhibitors--current status and future prospects.

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

  • K. SeibertY. Zhang P. Isakson
  • Medicine, Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1994
In an animal model of acute inflammation, a selective inhibitor of COX-2 inhibited edema at the inflammatory site and was analgesic but had no effect on PG production in the stomach and did not cause gastric toxicity.

Selective cyclooxygenase-2 inhibition by nimesulide in man.

The activity of nimesulide, a Cox-2 selective nonsteroidal antiinflammatory drug, in vitro against purified enzymes and in vivo in man was examined, suggesting that TX is largely Cox-1 derived.

Pharmacological analysis of cyclooxygenase-1 in inflammation.

  • C. SmithY. Zhang P. Isakson
  • Medicine, Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1998
The results suggest that, in addition to the role of peripherally produced PGs, there is a critical, centrally mediated neurological component to inflammatory pain that is mediated at least in part by COX-2.

Cyclooxygenase-2 specificity and its clinical implications.

Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs.

We have evaluated the selectivity in vitro of various conventional nonsteroidal anti-inflammatory drugs (NSAIDs) and new anti-inflammatory compounds (NS-398, L-745,337 and SC58125) in inhibiting the…
...